A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment. Sandia and BioBright are working to develop better security for this new commercial field.

PerkinElmer, announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for the American Institute of Certified Public Accountants (AICPA’s) Trust Service Principles of Security, Confidentiality and Availability. With the SOC 2 attestations, biotech and pharmaceutical companies have the added assurance that the PerkinElmer Signals solutions have been designed with intellectual property protection in mind.

Point-of-care testing (POCT) involving Radiometer’s blood gas and immunoassay analysers, has led to faster diagnoses and improved patient experience in the emergency department (ED) at Queen’s Hospital, Romford. A study by Clare Bailey, shows how Radiometer’s POCT ABL90 FLEX PLUS blood gas analysers and AQT90 FLEX immunoassay analysers have enabled the ED team to manage increasing patient numbers.

The Linkam THMS600 stage was used by researchers at the university to study the fluorescence of the nanoparticles that are produced. They used UV-Vis-NIR spectroscopy to characterize the nanomaterial’s emission spectra as a function of temperature, which then allowed them to use the catalogued emissions as in vitro luminescent nanothermometers. A recent study undertaken at Rovira i Virgili University in Tarragona, Spain, reveals that biolabeling through luminescence thermometry has the potential to detect cancer cells at an early stage of development,

Oxford Immunotec has entered into an extensive research collaboration with Public Health England (PHE), an executive agency of the UK’s Department for Health and Social Care (DHSC).

The new Thermo Scientific Tox Explorer Collection offers a comprehensive LC-MS workstream for toxicology assays. The Tox Explorer Collection consists of a comprehensive library of analytes, allowing for faster identification and targeted screening assays with 1,500 compounds confirmed in a single analysis.

Avacta Group plc is pleased to announce that the BAMS™ assay to detect the SARS-CoV-2 virus has been launched as a research kit1 by its partner Adeptrix. Up to one thousand samples per day can be analysed by a single technician using BAMS, making BAMS a very attractive high throughput technique for COVID-19 diagnosis and research.

Eppendorf introduces the refrigerated 24-place centrifuge 5425 R, the successor of its popular centrifuge 5424 R.

FUJIFILM Irvine Scientific, Inc., has become the exclusive, worldwide distributor of cellnest®, a recombinant peptide attachment substrate that provides optimal adhesion and proliferation of stem cells in chemically defined, animal component-free conditions.

EKF Diagnostics new viral transport media PrimeStore® MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation. Currently, samples require the use of high-containment laboratories to be studied safely. Inactivation allows for a higher rate of testing within more laboratories.